Expert Opinion on Therapeutic Patents
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.7 | Q1 | 78.4% | 1.098 | Q1 | 86.2% |
| 2024 | 4.6 | Q1 | 84.1% | 1.200 | Q1 | 88.4% |
| 2023 | 5.4 | Q1 | 91.6% | 1.291 | Q1 | 90.6% |
| 2022 | 6.6 | Q1 | 91.4% | 1.292 | Q1 | 91.0% |
| 2021 | 6.7 | Q1 | 89.2% | 1.065 | Q1 | 87.8% |
| 2020 | — | — | 1.121 | Q1 | 87.7% | |
| 2019 | — | — | 1.027 | Q1 | 86.2% | |
| 2018 | — | — | 1.018 | Q1 | 84.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1744-7674
ISSN
1354-3776
country
GBcoverage
1991-2026